ArticleJournal of racial and ethnic health disparities2026
Migraine-Related Burden, Treatment Interventions, and Healthcare Experiences by Race and Ethnicity: Results of the Migraine Report Card Survey.
Article in Journal of racial and ethnic health disparities, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Migraine studies consistently have low enrollment of non-White and/or Hispanic participants. This exploratory analysis assesses burden, treatment interventions, and care in people with high-frequency migraine and medication overuse (HFM + MO) in three racial/ethnic groups in the United States that responded to the Migraine Report Card online survey. The Migraine Report Card survey was fielded to adults (≥ 18 years). Eligible respondents reported current or previous HFM + MO (≥ 8 days/month with headache and ≥ 10 days/month of acute headache medication use over the last few months) and screened positive for migraine using the ID Migraine™ screener. Survey questions pertained to living with migraine, healthcare-patient communication, and treatment use and access. Subgroups large enough for analysis included non-Hispanic White, non-Hispanic Black, and Hispanic respondents currently experiencing HFM + MO. Acute medication optimization was assessed with the 4-item Migraine Treatment Optimization Questionnaire. Raw data were weighted to the US adult population. A total of 414 respondents currently experiencing HFM + MO were included in this analysis (White, n = 293; Black, n = 46; Hispanic, n = 75). In this population, despite similarities in migraine and insurance status, 54% of Black respondents reported being "very concerned" about their current health compared to 29% of White and 24% of Hispanic respondents. Twenty percent of White respondents reported using a preventive prescription migraine medication compared to 7% of Black and 10% of Hispanic respondents. Despite similar clinical and socioeconomic characteristics, healthcare disparities were observed, most notably among Black and Hispanic respondents experiencing HFM + MO. Further research regarding inequities in migraine care and disease impact is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.